Contacts, documents and full notice history are available with a subscription.
Special Notice NONE Expired 1 notice 1 document

Sprague-Dawley rats (Charles River) FDA-130321

Solicitation FDA-130321 Copied Notice ID 35f9b14ce93b44a1b327bb62ee2599e5 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FDA OFFICE OF ACQ GRANT SVCS
SAM.gov
Posted
Jul 14, 2025
Deadline
Jul 18, 2025
Set-aside
NONE
NAICS
112930
PSC
8820

Summary

AI-generated · Aug 24, 2025

Sourcing of Sprague-Dawley rats must be from Charles River Laboratories under a sole-source arrangement to support the toxicity studies of tobacco-derived nicotine after repeated inhalation (protocols E07877.01 and E07876.01). These studies require the same rat strain provided by Charles River for methods development to ensure consistent behavioral testing and data interpretation.

Maintaining this exact strain from the same supplier is essential for comparability across ongoing research; a change in strain or supplier would invalidate the studies, make initial efforts uninformative or unpublishable, and prevent results from supporting regulatory activities.

See attached Notice of Intent to Sole Source requirement for Sprague Dawley rats for protocols: E07877.01 and E07876.01 to access the toxicity of tobacco derived nicotine after repeated inhalation. Both studies will provide robust scientific data that will be used to identify and assess potential public health concerns related to nicotine inhalation exposures. This acquisition is restricted to Charles River Laboratories as these same rats were provided by Charles River for the methods development for the aforementioned approved protocols and it is imperative the lab continues using this specific strain from Charles River to ensure all behavioral testing and scientific data interpretation can be compared in ongoing research. A change in strain and supplier would result in invalidation of the studies of which any initial efforts will essentially be uninformative, unpublishable, nor can the results be used to support regulatory activities.

From Special Notice posted on Jul 14, 2025

Notice history

1
  1. Special Notice LATEST Posted Jul 14, 2025

Details

Solicitation number FDA-130321
Notice ID 35f9b14ce93b44a1b327bb62ee2599e5
Notice type Special Notice
Product / Service (PSC) 8820
NAICS 112930
Set-aside No Set aside used
Archive date Aug 02, 2025

Award Information

Not yet awarded

Documents

1
View on SAM.gov

Contacts

primary
Suzanne Martella

Email

Phone

8705437990

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FOOD AND DRUG ADMINISTRATION
FDA OFFICE OF ACQ GRANT SVCS

Dates

Posted Jul 14, 2025 1 year ago
Last Updated Aug 06, 2026 2 days ago
Due Jul 18, 2025 1 year ago